Qed Therapeutics Inc.

Clinical research in achondroplasia centers on pediatric growth disorders, with attention to long-term safety, tolerability, and changes in standing height Z-score. The sponsor’s trials include children across multiple age ranges, reflecting a sustained interest in skeletal dysplasia and growth-related outcomes.

• Pediatric growth impairment
• Long-term treatment safety
• Height-related efficacy measures

Research activity in this area also includes younger children and infants, indicating focus on early-life management of genetic short stature.